Boston Children's Hospital - Company Profile
Powered by 
All the data and insights you need on Boston Children's Hospital in one report.
$295
- Save hours of research time and resources with
our up-to-date Boston Children's Hospital Strategy Report
- Understand Boston Children's Hospital position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Boston Children's Hospital (Boston Children’s) is a pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium, and Boston University. Boston Children’s is headquartered in Boston, Massachusetts, the US.
Headquarters
United States of America
Address
300 Longwood Avenue, Boston, Massachusetts, 02115
Website
www.childrenshospital.org
Telephone
1 617 3556000
No of Employees
10,000
Industry
Pharmaceuticals and Healthcare
Boston Children's Hospital premium industry data and analytics
Products and Services
| Services |
|---|
| Acupuncture Service |
| Adult Congenital Heart Service |
| Andrology Program |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In October, the company entered into an agreement with Inimmune Corporation to develop novel and innovative small molecule vaccine adjuvants adjuvant is added to some vaccines. |
| 2023 | Contracts/Agreements | In June, the company entered into an agreement Franciscan Children’s. |
| 2022 | Corporate Changes/Expansions | In August, the company formed a new company co-founded by George Daley, M.D, Ph.D., and ElevateBio LLC to develop allogeneic immune cell therapies based on a novel platform that generates functionally mature immune cells from induced pluripotent stem cells. |
Competitor Comparison
| Key Parameters | Boston Children's Hospital | Pediatrix Medical Group Inc | Arkansas Children's Hospital | Children's Miracle Network Hospitals | Deaconess Associations Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Boston | Sunrise | Little Rock | Salt Lake | Cincinnati |
| State/Province | Massachusetts | Florida | Arkansas | Utah | Ohio |
| No. of Employees | 10,000 | 2,900 | 4,400 | - | - |
| Entity Type | Institution | Public | Institution | Institution | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kevin B. Churchwell, MD. | Chief Executive Officer; President | Senior Management | 2021 | - |
| Doug Vanderslice | Chief Financial Officer | Senior Management | - | - |
| Dick Argys | Chief Culture Officer; Executive Vice President | Senior Management | 2009 | - |
| Laura J. Wood | Chief Nursing Officer; Senior Vice President - Patient Care Services | Senior Management | - | - |
| John Brownstein, Ph.D. | Chief Innovation Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer